UBS Group’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-125,681
| Closed | -$1.26M | – | 8923 |
|
|
2023
Q4 | $1.26M | Buy |
125,681
+123,369
| +5,336% | +$1.24M | ﹤0.01% | 3263 |
|
|
2023
Q3 | $6.66K | Sell |
2,312
-424
| -15% | -$1.22K | ﹤0.01% | 6146 |
|
|
2023
Q2 | $10.4K | Buy |
2,736
+169
| +7% | +$644 | ﹤0.01% | 6063 |
|
|
2023
Q1 | $4.78K | Sell |
2,567
-1,030
| -29% | -$1.92K | ﹤0.01% | 7047 |
|
|
2022
Q4 | $8.27K | Sell |
3,597
-306
| -8% | -$704 | ﹤0.01% | 7598 |
|
|
2022
Q3 | $13K | Buy |
+3,903
| New | +$13K | ﹤0.01% | 6993 |
|
|
2022
Q1 | – | Sell |
-1,635
| Closed | -$10K | – | 9840 |
|
|
2021
Q4 | $10K | Buy |
+1,635
| New | +$10K | ﹤0.01% | 7694 |
|
|
2021
Q3 | – | Sell |
-422
| Closed | -$5K | – | 8959 |
|
|
2021
Q2 | $5K | Buy |
+422
| New | +$5K | ﹤0.01% | 7483 |
|